Advertisement

HLA-haploidentical bone marrow transplantation with post-transplant cyclophosphamide expands the donor pool for patients with sickle cell disease

Javier Bolaños-Meade, Ephraim J. Fuchs, Leo Luznik, Sophie M. Lanzkron, Christopher J. Gamper, Richard J. Jones, Robert A. Brodsky
PDF Container